Outcomes after Conversion to a Belatacept

Clin J Am Soc Nephrol. 2024 May 1;19(5):547. doi: 10.2215/CJN.0000000000000466.
No abstract available

Publication types

  • Letter

MeSH terms

  • Abatacept* / adverse effects
  • Abatacept* / therapeutic use
  • Drug Substitution
  • Female
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control
  • Humans
  • Immunosuppressive Agents* / adverse effects
  • Immunosuppressive Agents* / therapeutic use
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Abatacept
  • Immunosuppressive Agents